Broad markets proved resilient yet again on Wednesday even with the Fed deciding that could begin tapering as soon as November. ARK Funds rallied again with one big exception. ARKW performed the best out of the group, up 1.7%, while ARKG did the worst, down 0.6% on the day. The gains from last year are slowly sliding away, but Cathie Wood may have something up her sleeve as she is constantly reshuffling her ETFs to stand up to market headwinds.
ARK Invest has been the talk of Wall Street over the past couple of years, outperforming the market and solidifying its place among the big players in the investments world. Wood is the founder and head of this investment house, and many have compared her rising star to the likes of Warren Buffett.
Many traders are looking to mirror the plays of famous investors and huge brokerage firms to capitalize on the gains that the big dogs are making. Lucky for us, ARK Invest releases a list of its trades at the end of each trading day.
While some companies would require a subscription service or monetary fee to see what makes ARK Invest tick, here at 24/7 Wall St. we would rather give you the data for free. Here is a quick look at some of the major sales that ARK Invest executed on September 22, 2021. Also check out all the ARK Invest buys that took place that same day.
The ARK Fintech Innovation ETF (NYSEARCA: ARKF) deals mainly with up-and-coming fintech stocks, as the name suggests. Some of its biggest holdings include Square, Zillow, Pinterest, PayPal and Alibaba. Net assets for the fund are currently $4.0 billion. Here are some notable sales in this fund: NO SALES
ARK Genomic Revolution ETF (NYSEARCA: ARKG) looks at companies across multiple industries, but the general focus is on health care and companies that are changing the game technologically in this field. The biggest holdings are Pacific Biosciences, Teladoc Health, CRISPR and Fate Therapeutics. Net assets for the fund are currently $9.7 billion. Here are some notable sales in this fund: 241,747 shares of Novartis, 126,224 shares of Codexis, & 11,930 shares of Bristol-Myers.
ARK Innovation ETF (NYSEARCA: ARKK) has a particular focus on disruptive innovation across multiple industries, but primarily tech. Some of the biggest names are in this fund, including Tesla, Roku, Square, Zillow and Spotify. Net assets for this fund are currently $25.5 billion. Here are some notable sales in this fund: 66,750 shares of Intellia Therapeutics, 373,251 shares of Teradyne, 172,348 shares of Iridium Communications, & 128,900 shares of Nintendo.
ARK Autonomous Technology & Robotics ETF (NYSEARCA: ARKQ) is focused, unsurprisingly, on companies that are in the field of autonomous technology and robotics, specifically ones that are disruptively innovating. Big names in this fund include Tesla, Alphabet, JD.com, Baidu and Iridium. Net assets for this fund are currently $3.1 billion. Here are a few sales of note in this fund: 10,950 shares of NXP Semiconductors.
ARK Next Generation Internet ETF (NYSEARCA: ARKW) is focused on companies that are disruptively innovating within the theme of the next generation of the internet. Some names in this fund are similar to the others, including Tesla, Square, Grayscale Bitcoin Trust, Facebook and Snap. Net assets for this fund are currently $6.4 billion. Here are a couple of notable sales in this fund: 37,007 shares of Etsy.
Ark Space Exploration & Innovation ETF (NYSEARCA: ARKX) is focused primarily on companies developing technology around spaceflight. Big names in this fund include Trimble, Kratos, Nvidia, Amazon and Iridium. Net assets for this fund are currently $63.3 million. Sales worth noting in this fund: 1,803 shares of NVIDIA.
Check out all the sales here:
| FUND | Direction | Ticker | Name | Shares |
|---|---|---|---|---|
| ARKG | Sell | SMFR | SEMA4 HOLDINGS CORP | 12,280 |
| ARKG | Sell | NVS | NOVARTIS AG | 241,747 |
| ARKG | Sell | CLLS | CELLECTIS SA | 12,212 |
| ARKG | Sell | CDXS | CODEXIS INC | 126,224 |
| ARKG | Sell | BMY | BRISTOL-MYERS SQUIBB CO | 11,930 |
| ARKK | Sell | NTLA | INTELLIA THERAPEUTICS INC | 66,750 |
| ARKK | Sell | TER | TERADYNE INC | 373,251 |
| ARKK | Sell | IRDM | IRIDIUM COMMUNICATIONS INC | 172,348 |
| ARKK | Sell | SE | SEA LTD | 65,913 |
| ARKK | Sell | PRLB | PROTO LABS INC | 39,453 |
| ARKK | Sell | NSTG | NANOSTRING TECHNOLOGIES INC | 3,951 |
| ARKK | Sell | NTDOY | NINTENDO CO LTD | 128,900 |
| ARKQ | Sell | NXPI | NXP SEMICONDUCTORS NV | 10,950 |
| ARKW | Sell | ETSY | ETSY INC | 37,007 |
| ARKW | Sell | LC | LENDINGCLUB CORP | 7,623 |
| ARKW | Sell | SE | SEA LTD | 3,766 |
| ARKX | Sell | NVDA | NVIDIA CORP | 1,803 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of a673b.bigscoots-temp.com.
Travel Cards Are Getting Too Good To Ignore
Credit card companies are pulling out all the stops, with the issuers are offering insane travel rewards and perks.
We’re talking huge sign-up bonuses, points on every purchase, and benefits like lounge access, travel credits, and free hotel nights. For travelers, these rewards can add up to thousands of dollars in flights, upgrades, and luxury experiences every year.
It’s like getting paid to travel — and it’s available to qualified borrowers who know where to look.
We’ve rounded up some of the best travel credit cards on the market. Click here to see the list. Don’t miss these offers — they won’t be this good forever.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
